JRC Publications Repository

JRC Publications Repository >

Browsing by Author MORGENSTERN Alfred

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 89 to 108 of 136
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2007Pharmacokinetics and toxicity of 213Bi-labeled PAI2 in Preclinical Targeted Alpha Therapy for CancerSONG E.; ABBAS RIZVI S. M.; QU C. F.; RAJA C.; BRECHBIEL M. W.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B. J.Articles in Journals
2012Polymersomes as nano-carriers to retain harmful recoil nuclides in alpha radionuclide therapy: a feasibility studyTHIJSEN L.; SCHAART D.r.; DE VRIES D.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DENKOVA A.g.Articles in Journals
2005Pre-clinical Study of 213Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic CancerQU C.f.; SONG E.; LI Y.; RIZVI S.m.a.; RAJA C.; ROSS R; APOSTOLIDIS CHRISTOS; ALLEN Barry J.; MORGENSTERN ALFREDArticles in Journals
2006Preclinical Studies of Bismuth-213 Labeled Plasminogen Activator Inhibitor Type 2 (PAI2) in a Prostate Cancer Nude Mouse Xenograft ModelRIZVI S.m.a.; LI Y.; SONG E.; QU C.f.; RAJA C.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B.j.Articles in Journals
2008Preparation and Testing of Bevacizumab Radioimmunoconjugates with Bismuth-213 and Bismuth-205 / Bismuth-206RIZVI S.; SONG E.; RAJA C.; BERETOV J.; MORGENSTERN Alfred; APOSTOLIDIS Christos; RUSSELL P. J.; KEARSLEY J.; ABBAS Kamel; ALLEN B. J.Articles in Journals
2008Production of 230U/226Th for Targeted Alpha Therapy via Proton Irradiation of 231PaMORGENSTERN Alfred; LEBEDA O.; STURSA J.; BRUCHERTSEIFER Frank; CAPOTE R.; MCGINLEY John; RASMUSSEN Gert; SIN M.; ZIELINSKA B.; APOSTOLIDIS ChristosArticles in Journals
2005Production of Ac-225 from Th-229 for Targeted Alpha TherapyAPOSTOLIDIS CHRISTOS; MOLINET Roger; MORGENSTERN ALFREDArticles in Journals
2008Production of Alpha Emitters for Targeted Alpha TherapyMORGENSTERN Alfred; ABBAS Kamel; BRUCHERTSEIFER Frank; APOSTOLIDIS ChristosArticles in Journals
2008Production of Alpha Emitting Radionuclides for Nuclear MedicineMORGENSTERN Alfred; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankArticles in books
2008Radiofungicidal Effects of External Gamma Radiation and Antibody-Targeted Beta and Alpha Radiation on Cryptococcus neoformansBRYAN R. A.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; CASADEVALL A.; DADACHOVA E.Articles in Journals
2009Radioimmunotherapy Is Effective Against High-Inoculum Cryptococcus Neoformans Infection in Mice and Does Not Select for Radiation-Resistant Cryptococcal CellsBRYAN R. A.; JIANG Z.; HUANG X.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SELLERS R.; CASADEVALL A.; DADACHOVA E.Articles in Journals
2010Radioimmunotherapy is More Effective than Antifungal Treatment in Experimental Cryptococcal InfectionBRYAN R. A.; JIANG Z.; HOWELL Roberta; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; CASADEVALL A.; DADACHOVA E.Articles in Journals
2009Radioimmunotherapy of Breast Cancer Metastases with Alpha-Particle-emitter 225Ac: Comparing Efficacy with 213Bi, 90YSONG Hong; HOBBS Robert F.; VAJRAVELU Ravy; HUSO David L.; ESAIAS Caroline; APOSTOLIDIS Christos; MORGENSTERN Alfred; SGOUROS GeorgeArticles in Journals
2013Radioimmunotherapy of Cryptococcus neoformans Spares Bystander Mammalian CellsBRYAN R. A.; JIANG Z.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; Casadevall Arturo; DADACHOVA E.Articles in Journals
2009Radioimmunotherapy of human bladder cancer in a nude mouse model comparing Bi-213-anti-EGFR-MAb and Th-226-anti-EGFR-MAbPFOST B.; MORGENSTERN Alfred; SEIDL C.; BRUCHERTSEIFER Frank; AUTENRIETH M.; APOSTOLIDIS Christos; ABBAS Kamel; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2012Radioimmunotherapy of pancreatic cancer with 213Bi-labeled antibodies to intranuclear histonesDADACHOVA E.; BRYAN R. A.; JIANG Z.; JANDL T; STRAUSS J; KOBA W; SELLERS R.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; EPSTEIN AContributions to Conferences
2009Radiolabeled Antibodies to Bacillus Anthracis Toxins are Bactericidal and Partially Therapeutic in Experimental Murine AnthraxRIVERA J.; NAKOUZI A.s.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DADACHOVA E.Articles in Journals
2012Radiopeptidtherapie des Ovarialkarzinoms mit Alphastrahlern: Verbesserte Tumorkontrolle durch Kombination von 213Bi-DTPA-F3 mit Taxol bei irreversiblen Zellzyklusarrest von Ovarialkarzinomzellen in der G2/M-PhaseSEIDL C.; VALLON M.; BLECHERT B.; GÄRTNER Florian; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.Contributions to Conferences
2013Retention studies in polymer vesicles of recoiling atoms as a result of alpha decayWANG G.; VAN BUEREN J; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; WOLTERBEEK H.th.; MENDES E; DENKOVA A.g.Contributions to Conferences
2014Retention studies of recoiling daughter nuclides of 225Ac in polymer vesiclesWANG G.; DE KRUIJFF R. M.; ROL A; THIJSSEN L.; MENDES E; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; STUART M.c.a.; WOLTERBEEK H.th.; DENKOVA A.g.Articles in Journals
Showing results 89 to 108 of 136

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top